Abstract: The present invention provides compositions and methods for treating a hypophosphatemic disorder, such as X-linked hypophosphatemia (XLH). The method entails administering to a subject a pharmaceutical composition containing an anti-FGF23 ligand, wherein the dosing regimen of the pharmaceutical is designed to reach effective and efficient control of FGF23 activity.

Abstract: The present invention provides compositions and methods for treating tumor-induced osteomalacia. The method entails administering to a subject a pharmaceutical composition containing an anti-FGF23 ligand, wherein the dosing regimen of the pharmaceutical is designed to reach effective and efficient control of FGF23 activity.

Abstract: The present invention provides compositions and methods for treating a hypophosphatemic disorder, such as X-linked hypophosphatemia (XLH). The method entails administering to a subject a pharmaceutical composition containing an anti-FGF23 ligand, wherein the dosing regimen of the pharmaceutical is designed to reach effective and efficient control of FGF23 activity.

Abstract: The present invention provides compositions and methods for treating a hypophosphatemic disorder, such as X-linked hypophosphatemia (XLH). The method entails administering to a subject a pharmaceutical composition containing an anti-FGF23 ligand, wherein the dosing regimen of the pharmaceutical is designed to reach effective and efficient control of FGF23 activity.

Abstract: The present invention provides compositions and methods for treating a hypophosphatemic disorder, such as X-linked hypophosphatemia (XLH). The method entails administering to a subject a pharmaceutical composition containing an anti-FGF23 ligand, wherein the dosing regimen of the pharmaceutical is designed to reach effective and efficient control of FGF23 activity.

Abstract: The present invention provides compositions and methods for treating a hypophosphatemic disorder, such as X-linked hypophosphatemia (XLH). The method entails administering to a subject a pharmaceutical composition containing an anti-FGF23 ligand, wherein the dosing regimen of the pharmaceutical is designed to reach effective and efficient control of FGF23 activity.

Abstract: Provided is an arthritis treatment method and an arthritis treatment system which can be effective for the short-term attainment of a pain relief effect. An arthritis treatment method includes an instrument introducing step of causing at least one instrument having a tubular shape to communicate with a lesion area in which crystal-induced arthritis occurs, and a treatment step of removing a causative agent of the crystal-induced arthritis from the lesion area by perfusion and discharge of a lavage fluid through the instrument.

Abstract: Provided is a mobile electronic device, comprising a first display, a second display that overlaps with the first display and configured to be switched between a transmissive state that passes incident light and a reflective state that reflects incident light, and a controller configured to control display of a first screen for the first display and a second screen for the second display, wherein the controller switches at least part of the second display to the transmissive state to cause the first display to display the first screen, and causes the second display to display the second screen in accordance with a condition.

Abstract: In order to enable easier magnification and reduction of a displayed image, an electronic device 1 includes a display unit 30, a pressure detection unit 60 and a control unit 10, such that the display unit 30 displays an image, the pressure detection unit 60 detects a pressure, and the control unit 10, based on the pressure detected by the pressure detection unit 60, controls magnification or reduction of the image.

Abstract: Provided is an arthritis treatment method and an arthritis treatment system which can be effective for the short-term attainment of a pain relief effect. An arthritis treatment method includes an instrument introducing step of causing at least one instrument having a tubular shape to communicate with a lesion area in which crystal-induced arthritis occurs, and a treatment step of removing a causative agent of the crystal-induced arthritis from the lesion area by perfusion and discharge of a lavage fluid through the instrument.

Abstract: According to an aspect, an electronic device includes: a piezoelectric element; and a sound generating unit that is vibrated by the piezoelectric element and generates a vibration sound transmitted by vibrating part of a human body. The electronic device notifies a user of a specific position in the sound generating unit.

Abstract: According to an aspect, an electronic device includes: a piezoelectric element; a sound generating unit that is vibrated by the piezoelectric element and generates a vibration sound to be transmitted while vibrating part of a human body; and a detection unit that detects contact of the part of the human body with the sound generating unit. A volume of the vibration sound is changed corresponding to a detection result of the detection unit.

Abstract: According to an aspect, a mobile electronic device includes a touch panel and a control unit. The touch panel displays a screen thereon and detects a gesture performed on a surface thereof. When a sweep gesture is detected by the touch panel, the control unit cause an object corresponding to a process, which is executable while the screen is displayed on the touch panel, to be displayed near a position where the sweep gesture is detected on the touch panel.

Abstract: According to an aspect, an information processing device includes: a touch panel for detecting a contact; and a controller configured to display a virtual keyboard including a plurality of buttons on the touch panel, and receive, when the touch panel detects a contact started at a first position on the surface of the touch panel and terminated at a second position on the surface of the touch panel, a character string including characters corresponding to the buttons displayed on a trajectory obtained by connecting each position at which the contact is detected from when the contact is started at the first position to when the contact is terminated at the second position as input.

Abstract: The present invention provides compositions and methods for treating a hypophosphatemic disorder, such as X-linked hypophosphatemia (XLH). The method entails administering to a subject a pharmaceutical composition containing an anti-FGF23 ligand, wherein the dosing regimen of the pharmaceutical is designed to reach effective and efficient control of FGF23 activity.

Abstract: A mobile phone terminal includes a touch panel that detects a gesture with respect to a display surface thereof, and a control unit that displays a plurality of buttons on the display surface of the touch panel. When the touch panel detects a gesture in which touch is started at a first position on the touch panel and is maintained to a second position on the touch panel, the control unit displays a character string obtained by prediction processing or conversion processing based on a character string including characters corresponding to buttons displayed on a trajectory obtained by connecting each position in which the touch is detected from when the touch is started at the first position to when the touch is maintained to the second position in a predetermined area on the touch panel as a candidate of a character string input by the gesture.

Abstract: According to an aspect, an electronic device includes a display unit, an operation unit, and a control unit. The display unit displays a screen corresponding to an application during execution thereof. The operation unit is operated in order to input a character. When an operation for a character input is performed through the operation unit while the screen corresponding to the application is displayed on the display unit, the control unit displays an input character on the display unit while maintaining a state in which the screen corresponding to the application before the character is input is displayed.

Abstract: According to an aspect, an electronic device includes: a piezoelectric element; and a sound generating unit that is vibrated by the piezoelectric element and generates a vibration sound transmitted by vibrating part of a human body. The electronic device notifies a user of a specific position in the sound generating unit.

Abstract: According to an aspect, a character input device includes: a display unit; a touch sensor for detecting a contact with a surface thereof; a character recognition processing unit for performing a first character recognition process for recognizing a character used for a first function and a second character recognition process for recognizing a character used for a second function, on the basis of a locus connecting positions where the contact is detected by the touch sensor; and an input control unit for displaying, on the display unit, a first input screen for the first function onto which the character recognized by the first character recognition process is input and/or a second input screen for the second function onto which the character recognized by the second character recognition process is input.

Abstract: According to an aspect, a character input device includes: a touch panel capable of detecting touches on a plurality of points; and a control unit for displaying a plurality of buttons on the touch panel and determining whether a first touch gesture in which a touch position with respect to the touch panel is continuously changed occurs. When detecting occurrence of a second touch gesture being a further touch on a different area from an area where the first touch gesture occurs while the first touch gesture occurs in the area where the buttons are displayed, the control unit is configured to receive, as an input, a character corresponding to the button corresponding to the touch position of the first touch gesture when the second touch gesture occurs.